Common use of Data and Information Transfer Clause in Contracts

Data and Information Transfer. To the extent permitted by law, RayzeBio shall promptly provide access to PeptiDream data, information, materials, sequences, and documentation generated by or on behalf of RayzeBio with respect to such Licensed Product prior to the Option Notice (“RayzeBio Data Transfer”) as reasonably necessary to Develop, Manufacture, and Commercialize. No later than [***] days after the Option Notice, the Parties will use commercially reasonable efforts to enter into a written agreement setting forth [***] for the Parties with respect to such Licensed Product. Following the Option Notice, each Party will promptly provide the other Party with copies of relevant data and results and relevant supporting documentation (e.g., protocols, case report forms and analysis plans) Controlled by such Party that are generated by or on behalf of such Party or its Affiliates, Sublicensees, or PeptiDream Sublicensees, if applicable, in the Development of such Licensed Product. PeptiDream agrees to reasonably compensate RayzeBio for its time and activities related to each RayzeBio Data Transfer and will obtain written permission from RayzeBio before relying on any information received, such written permission not to be unreasonably withheld, conditioned or delayed. PeptiDream is solely responsible for correcting any gap between the information provided and Japan regulatory requirements.

Appears in 2 contracts

Sources: License and Research Collaboration Agreement (RayzeBio, Inc.), License and Research Collaboration Agreement (RayzeBio, Inc.)